Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases

Amber L. Simpson,Jacob Peoples,John M. Creasy,Gabor Fichtinger,Natalie Gangai,Krishna N. Keshavamurthy,Andras Lasso,Jinru Shia,Michael I. D’Angelica,Richard K. G. Do

DOI: https://doi.org/10.1038/s41597-024-02981-2

2024-02-07

Scientific Data

Abstract:The liver is a common site for the development of metastases in colorectal cancer. Treatment selection for patients with colorectal liver metastases (CRLM) is difficult; although hepatic resection will cure a minority of CRLM patients, recurrence is common. Reliable preoperative prediction of recurrence could therefore be a valuable tool for physicians in selecting the best candidates for hepatic resection in the treatment of CRLM. It has been hypothesized that evidence for recurrence could be found via quantitative image analysis on preoperative CT imaging of the future liver remnant before resection. To investigate this hypothesis, we have collected preoperative hepatic CT scans, clinicopathologic data, and recurrence/survival data, from a large, single-institution series of patients (n = 197) who underwent hepatic resection of CRLM. For each patient, we also created segmentations of the liver, vessels, tumors, and future liver remnant. The largest of its kind, this dataset is a resource that may aid in the development of quantitative imaging biomarkers and machine learning models for the prediction of post-resection hepatic recurrence of CRLM.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper focuses on improving the accuracy of prognosis prediction for patients with colorectal liver metastasis (CRLM). Currently, although hepatectomy can cure some CRLM patients, recurrence is common. The research team hypothesized that by quantitatively analyzing the image features of future liver remnant (FLR) in preoperative CT imaging, recurrence can be predicted before surgery, thereby assisting doctors in selecting the most suitable patients for hepatectomy. To accomplish this, they collected a large dataset (197 cases) of CT scans, clinical pathology data, and recurrence/survival data from patients undergoing CRLM hepatectomy, and created segmented images of the liver, vessels, tumors, and FLR. These data are intended to facilitate the development of quantitative imaging biomarkers and machine learning models for predicting intrahepatic recurrence after CRLM surgery.